## CRDO: Credo Technology Group Holding Ltd - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.10 indicates fundamental undervaluation. Quality metrics strong (ROE 23%, ROA 12%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($145.10)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. 1832 Asset Management L.P. Takes Position in Credo Technology Group Holding Ltd. $CRDO**
- Source: MarketBeat | 20251205T040103 | Bullish | Relevance: 100%
- 1832 Asset Management L.P. has acquired a new position of 890,800 shares in Credo Technology Group Holding Ltd. (NASDAQ:CRDO) worth approximately $82.48 million, making institutional investors collectively own about 80.46% of the company's stock. This move comes as Credo Technology reported strong quarterly earnings, beating analyst expectations with $0.67 EPS and $268.03 million in revenue, leading to multiple analysts raising their price targets for the stock. Despite some insider selling, the company's shares are performing well, with a 0.4% increase and a market capitalization of $32.73 billion.

**2. Needham Maintains Credo Technology Group Holding (CRDO) Buy Recommendation**
- Source: Nasdaq | 20251204T050836 | Somewhat-Bullish | Relevance: 100%
- Needham has reiterated its "Buy" recommendation for Credo Technology Group Holding (CRDO) following a December 2, 2025 report. Despite an anticipated 2.19% downside from the current price, the average one-year price target for CRDO is $167.38/share, with projected annual revenue of $524MM and non-GAAP EPS of $1.40. Institutional ownership of CRDO has increased, indicating a bullish outlook.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Roth Capital | $250 | $170 | +47% |
| 2025-12-02 | Mizuho | $225 | $165 | +36% |
| 2025-12-02 | B of A Securiti | $240 | $165 | +45% |
| 2025-12-02 | Barclays | $220 | $165 | +33% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-12-02 | Mizuho | main | Outperform |
| 2025-12-02 | B of A Securiti | main | Buy |
| 2025-12-02 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 29 ($34.33M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 9.7% (+18.1%)
- Vanguard Group Inc: 9.2% (+0.9%)
- JPMORGAN CHASE & CO: 8.5% (+136.6%)
- Price (T.Rowe) Assoc: 3.0% (+563.8%)
- Point72 Asset Manage: 2.6% (+15.3%)

### Key Risks

1. High beta (2.63) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $34M sold (29 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +36%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.10 indicates undervaluation relative to growth. Quality metrics strong (ROE 23%, ROA 12%, margin 27%). Balance sheet: strong liquidity (8.9x), low leverage (D/E 0.13). Revenue growth strong at 40% YoY. Analyst sentiment positive (5 raises, avg +36%). Insider selling cluster ($34.3M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.2B |
| Beta | 2.63 |
| 52W Range | $29.09 - $213.80 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.10 |
| Forward P/E | 47.3 |
| Current P/E | 63.3 |
| YoY Growth | 34.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at 8.1% (minimal 5-day change). Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 (-3.4%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 10.4% shows strong absolute momentum above own 20MA. Outperforming sector by 7.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.35), confirming momentum. RSI neutral at 57. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.08% (CS: 93) | Strong |
| RSI_14 | 57.0 | Neutral |
| MACD Histogram | 3.35 | Bullish |
| vs SMA20 | 1.104x | Above |
| vs SMA50 | 1.137x | Above |
| vs SMA200 | 1.755x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $176.04
- **Stop Loss:** $145.10 (17.6% risk)
- **Target:** $237.92 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $5,633.28
- **Portfolio %:** 5.63%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-03-03 (Est: $0.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.50 | $0.67 | +35.3% |
| 2025Q3 | $0.36 | $0.52 | +44.2% |
| 2025Q2 | $0.27 | $0.35 | +27.9% |
| 2025Q1 | $0.18 | $0.25 | +36.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*